This inventor holds 2 USPTO granted patents. Top assignee: Saint Louis University. Active years: 2015-2022.
Company Filing History:
Years Active: 2015-2022
Title: David Collier Wood: Innovator in Biomedical Research
Introduction
David Collier Wood is a notable inventor based in Wildwood, MO (US). He has made significant contributions to the field of biomedical research, particularly in the development of innovative treatments for various medical conditions. With a total of 2 patents, his work has the potential to impact patient care and therapeutic strategies.
Latest Patents
Wood's latest patents include groundbreaking inventions. The first patent focuses on "Fatty acid modified human epidermal growth factor," which provides new epidermal growth factor (EGF)-based reagents modified by fatty acid conjugation. This invention also describes methods for using these agents to treat Short Bowel Syndrome (SBS). The second patent involves the "Expression of thrombin variants," which contemplates a mutant E-WE thrombin precursor containing specific amino acid residue sequences. This invention aims to enhance the treatment and prevention of thrombosis in mammals using a composition that includes mutant thrombin.
Career Highlights
David Collier Wood is affiliated with Saint Louis University, where he conducts research and develops innovative solutions in the biomedical field. His work is characterized by a commitment to advancing medical science and improving patient outcomes through his inventions.
Collaborations
Wood collaborates with esteemed colleagues, including Peter G Ruminski and Andras Gruber, to further enhance the impact of his research and inventions.
Conclusion
David Collier Wood is a distinguished inventor whose contributions to biomedical research are noteworthy. His innovative patents and collaborations reflect his dedication to improving healthcare through scientific advancements.